This author has yet to write their bio.
Meanwhile lets just say that we are proud sandbox contributed a whooping 5 entries.
- Eyenovia highlights Recent Progress in Three Phase 3 Programs, NDA Review Progress and Licensing Agreements Totaling up to $100 Million in Potential Pre-Commercial Revenue June 15, 2021
- Eyenovia Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of MicroLine for the Treatment of Presbyopia May 25, 2021
- Eyenovia Announces New $25 Million Credit Facility with Silicon Valley Bank May 10, 2021
295 Madison Avenue
New York, NY 10017